Systemic Inflammation Indexes and Risk of Immune-related Adverse Events in Patients With Metastatic Urothelial Carcinoma Treated With Immunotherapy
Low baseline NLR, PLR, and SII and good PS are associated with a higher risk of developing irAEs in patients treated with ICIs for mUC.
Authors
- Francesco Pierantoni (ORCID: https://orcid.org/0000-0002-8483-0196)
- Eleonora Lai (ORCID: https://orcid.org/0000-0001-7726-1864)
- Davide Bimbatti (ORCID: https://orcid.org/0000-0001-8177-5374)
- Marco Maruzzo (ORCID: https://orcid.org/0000-0002-6256-9249)
- Michele Dionese (ORCID: https://orcid.org/0000-0002-3964-2866)
- Nicolò Cavasin
- Elisa Erbetta
- Umberto Basso (ORCID: https://orcid.org/0000-0002-5075-2177)
- Salim Jubran
Institutions
- University of Padua (IT)
- Azienda Ospedaliero Universitaria Ospedali Riuniti (IT)
- Istituto Oncologico Veneto (IT)
- Istituti di Ricovero e Cura a Carattere Scientifico (IT)
Publication Details
- Journal
- Anticancer Research
- Published
- 2024-09-30
- DOI
- https://doi.org/10.21873/anticanres.17267
- Citations
- 3
- Primary Topic
- Cancer Immunotherapy and Biomarkers
- Type
- article
- Field-Weighted Citation Impact
- 0.85
Funders
- Ministero della Salute